Am J Transplant, Volume 17, Suppl 3 Archives - Page 136 of 181 - ATC Abstracts

2017 American Transplant Congress
Expectations and Experiences of Follow-Up and Self-Care After Living Kidney Donation: A Focus Group Study.
K. Manera,^1,2 C. Hanson,^1,2 J. Chapman,³ J. Kanellis,^4,5 J. Gill,⁶ J. Craig,^1,2 S. Chadban,^7,8 G. Wong,^1,2,3 A. Ralph,^1,2 A. Tong.^1,2
¹Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia; ²Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia; ³Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia; ⁴Department of Nephrology, Monash Medical Centre, Clayton, VIC, Australia; ⁵Department of Medicine, Monash University, Clayton, VIC, Australia; ⁶Division of Nephrology, University of British Columbia, Vancouver, BC, Canada; ⁷Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia
Background: Ensuring donor wellbeing warrants ongoing monitoring following living kidney donation. However, there is considerable variability in donor follow up processes, including information provided to…
2017 American Transplant Congress
Adjunctive Thymoglobulin with Proteasome Inhibitor Based Treatment of Late Mixed Acute Rejection.
A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ A. Shields,² F. Paterno,¹ A. Govil,¹ M. Anand,¹ T. Diwan,¹ J. Kremer,² R. Alloway,¹ E. Woodle.¹
¹University of Cincinnati, Cincinnati; ²The Christ Hospital, Cincinnati
Proteasome inhibitor (PI) containing regimens treat mixed acute rejection (MAR) at least in part due to elimination of donor specific antibody (DSA) and via effects…
2017 American Transplant Congress
Perceived Legitimacy of Using Social Support for Transplant Eligibility: Results from a National Survey of Transplant Clinicians.
K. Ladin,¹ E. Gordon,² Z. Butt,² T. Lavelle,¹ N. Daniels,³ D. Hanto.⁴
¹Tufts University, Medford, MA; ²Northwestern University School of Medicine, Chicago; ³Harvard University, Boston; ⁴Vanderbilt University School of Medicine, Nashville
Background: Although the Centers for Medicare and Medicaid Services require that social support be used to determine transplant eligibility, guidance is vague. Centers vary significantly…
2017 American Transplant Congress
Use of Modified Geriatric Assessment in Evaluation of Older Adults for Kidney Transplant Suitability.
K. Campbell,¹ F. Enger, E. Patrick,² M. Saunders,³ M. Josephson,¹ Y. Becker.²
¹Medicine, University of Chicago, Chicago, IL; ²Kidney Transplant, University of Chicago, Chicago, IL; ³Hospital Medicine, University of Chicago, Chicago, IL
BackgroundThere is an increasing incidence and prevalence of older adults with ESRD. Per guideline recommendations, many of these patients are now being considered for kidney…
2017 American Transplant Congress
Transplanting Hepatitis C Kidneys into Negative KidnEy Recipients [THINKER] Trial.
D. Goldberg, E. Blumberg, R. Reddy, S. Nazarian, V. Van Deerlin, J. Trofe-Clarke, M. Levine, D. Sawinski, R. Bloom, P. Abt, P. Reese.
University of Pennsylvania, Philadelphia
Background: More than 500 kidneys from HCV+ deceased donors are discarded each year, even though direct acting antiviral therapies have cure rates exceeding 95%. We…
2017 American Transplant Congress
Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.
M. Manook,^1,2 J. Kwun,¹ J. Yoon,¹ K. Samy,¹ A. MacDonlad,¹ H. Xu,¹ R. Smith,³ S. Sacks,³ A. Dorling,³ N. Mamode,² S. Knechtle.¹
¹Surgery, Duke Transplant Center, Durham, NC; ²Renal and Transplant, Guy's and St Thomas's NHS Foundation Trust, Sondon, United Kingdom; ³MRC Centre for Transplantation, London, United Kingdom
Introduction:Thrombotic microangiopathy (TMA) is a phenomenon observed in antibody-mediated rejection (AMR) of the kidney transplant, particularly in highly sensitized individuals. Following promising data in a…
2017 American Transplant Congress
To Accept or Not Accept, That Is the Question: Donor Heart Selection Process and Outcome of Discarded Organs Transplanted in Another Center.
A. Aliabadi-Zuckermann,¹ J. Goekler,¹ A. Kaider,² J. Riebandt,¹ R. Moayedifar,¹ E. Osorio,¹ T. Haberl,¹ G. Laufer,¹ J. Smits,³ A. Zuckermann.¹
¹Cardiac Surgery, Medical University of Vienna, Vienna, Austria; ²Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria; ³Eurotransplant Foundation, Leiden, Netherlands
Purpose: The decision making process to accept a donor heart is very complicated, subjective and less associated with evidence based decisions. In this analysis we…
2017 American Transplant Congress
Blood Transfusion Induced Donor Specific Antibodies Are Associated with Rejection and Graft Failure.
S. Hassan,¹ F. Regan,^2,3 C. Brown,⁴ A. Harmer,³ N. Anderson,³ P. Brookes,⁵ D. Taube,¹ M. Willicombe.¹
¹Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; ²Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom; ³NHS Blood and Transplant, London, United Kingdom; ⁴Histocompatibility and Immunogenetics, NHS Blood and Transplant, London, United Kingdom; ⁵Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom
Introduction: Although it is well known that blood transfusions post-transplant are associated with the development of both HLA and donor specific antibodies [DSAs] and a…
2017 American Transplant Congress
HLA Eplet Mismatches Predict DSA Formation, Graft Survival, and Re-Transplantation Rate in Pediatric Renal Transplantation.
M. Sypek,^1,2 S. Hiho,³ L. Cantwell,³ P. Hughes,² A. Le Page,⁴ J. Kausman.¹
¹Royal Children's Hospital, Melbourne, Australia; ²Royal Melbourne Hospital, Melbourne, Australia; ³Victorian Transplant and Immunogenetics Service, Melbourne, Australia; ⁴Monash Children's Hospital, Melbourne, Australia
The potential benefits of HLA epitope based matching are greatest for pediatric recipients, however, there is little published data on the association of epitope mismatches…
2017 American Transplant Congress
Assessing Self-Efficacy During the Transition from Pediatric to Adult Liver Transplant Care.
J. Bilhartz, M. Lopez, S. Eder, E. Fredericks.
University of Michigan, Ann Arbor, MI
Purpose: As part of ongoing quality improvement efforts, this project aimed to investigate changes in self-efficacy among adolescent / young adult liver transplant recipients participating…